BR0314647A - Uso de derivados de 4-piridilmetil-ftalazina para a preparação de um medicamento para o tratamento de sìndromes melodisplásicas - Google Patents

Uso de derivados de 4-piridilmetil-ftalazina para a preparação de um medicamento para o tratamento de sìndromes melodisplásicas

Info

Publication number
BR0314647A
BR0314647A BR0314647-2A BR0314647A BR0314647A BR 0314647 A BR0314647 A BR 0314647A BR 0314647 A BR0314647 A BR 0314647A BR 0314647 A BR0314647 A BR 0314647A
Authority
BR
Brazil
Prior art keywords
syndromes
pyridylmethylphthalazine
melodysplastic
medicament
derivatives
Prior art date
Application number
BR0314647-2A
Other languages
English (en)
Inventor
Margaret Han Dugan
Alan List
Original Assignee
Novartis Ag
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Univ Arizona filed Critical Novartis Ag
Publication of BR0314647A publication Critical patent/BR0314647A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE DERIVADOS DE 4-PIRIDILMETIL-FTALAZINA PARA A PREPARAçãO DE UM MEDICAMENTO PARA O TRATAMENTO DE SìNDROMES MIELODISPLáSICAS". A presente invenção refere-se a um método para tratar síndromes mielodisplásicas compreendendo administrar uma quantidade terapeuticamente eficaz de um derivado de 4-piridilmetil-ftalazina a um animal de sangue quente que necessite da mesma.
BR0314647-2A 2002-09-24 2003-09-23 Uso de derivados de 4-piridilmetil-ftalazina para a preparação de um medicamento para o tratamento de sìndromes melodisplásicas BR0314647A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41317602P 2002-09-24 2002-09-24
PCT/EP2003/010578 WO2004028542A1 (en) 2002-09-24 2003-09-23 Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Publications (1)

Publication Number Publication Date
BR0314647A true BR0314647A (pt) 2005-08-02

Family

ID=32043216

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314647-2A BR0314647A (pt) 2002-09-24 2003-09-23 Uso de derivados de 4-piridilmetil-ftalazina para a preparação de um medicamento para o tratamento de sìndromes melodisplásicas

Country Status (22)

Country Link
US (1) US20060128716A1 (pt)
EP (1) EP1545534B1 (pt)
JP (1) JP2006502195A (pt)
KR (1) KR20050074450A (pt)
CN (1) CN100372535C (pt)
AT (1) ATE359789T1 (pt)
AU (1) AU2003299065B2 (pt)
BR (1) BR0314647A (pt)
CA (1) CA2499738A1 (pt)
CR (1) CR7754A (pt)
DE (1) DE60313344T2 (pt)
EC (1) ECSP055700A (pt)
ES (1) ES2285251T3 (pt)
HR (1) HRP20050281A2 (pt)
MX (1) MXPA05003161A (pt)
NO (1) NO20051936L (pt)
PL (1) PL374696A1 (pt)
PT (1) PT1545534E (pt)
RS (1) RS20050228A (pt)
RU (1) RU2353364C2 (pt)
WO (1) WO2004028542A1 (pt)
ZA (1) ZA200502212B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1374875A3 (en) * 1997-10-15 2004-01-07 Polarx Biopharmaceuticals, Inc. Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome
CN101277939A (zh) 2005-09-09 2008-10-01 布里斯托尔-迈尔斯斯奎布公司 无环ikur抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132458B2 (en) * 1994-08-10 2006-11-07 Chemaphor Inc. Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
BR0009507A (pt) * 1999-03-30 2002-01-15 Novartis Ag Derivados de ftalazina para o tratamento de doenças inflamatórias
AR025068A1 (es) * 1999-08-10 2002-11-06 Bayer Corp Pirazinas sustituidas y piridazinas fusionadas, composicion farmaceutica que las comprenden, uso de dichos compuestos para la manufactura de un medicamentocon actividad inhibidora de angiogenesis
ES2531547T3 (es) * 1999-12-06 2015-03-17 Geistlich Pharma Ag Uso de taurolidina o el taurultamo para la fabricación de un medicamento para el tratamiento de tumores

Also Published As

Publication number Publication date
RU2353364C2 (ru) 2009-04-27
US20060128716A1 (en) 2006-06-15
ES2285251T3 (es) 2007-11-16
KR20050074450A (ko) 2005-07-18
PL374696A1 (en) 2005-10-31
MXPA05003161A (es) 2005-09-12
ZA200502212B (en) 2006-02-22
CR7754A (es) 2005-12-02
CA2499738A1 (en) 2004-04-08
PT1545534E (pt) 2007-06-22
JP2006502195A (ja) 2006-01-19
RU2005112711A (ru) 2006-02-27
AU2003299065B2 (en) 2006-10-26
ECSP055700A (es) 2005-08-11
DE60313344T2 (de) 2008-01-03
EP1545534A1 (en) 2005-06-29
HRP20050281A2 (en) 2006-07-31
CN1684684A (zh) 2005-10-19
AU2003299065A1 (en) 2004-04-19
ATE359789T1 (de) 2007-05-15
EP1545534B1 (en) 2007-04-18
DE60313344D1 (de) 2007-05-31
WO2004028542A1 (en) 2004-04-08
RS20050228A (en) 2007-08-03
CN100372535C (zh) 2008-03-05
NO20051936L (no) 2005-06-23

Similar Documents

Publication Publication Date Title
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
BRPI0407922A (pt) derivados de isoquinolina e métodos de uso destes
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
BR0315337A (pt) Composto, formulação farmacêutica, e, método para tratar câncer
IS6891A (is) Aðferðir við gjöf epóþílon hliðstæðna við meðferðkrabbameins
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
NO20024646D0 (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
SE0004101D0 (sv) New use
PT1231915E (pt) Uso de derivados de pleuromutilina para tratamento transdermal de doencas bacterianas
BR0314647A (pt) Uso de derivados de 4-piridilmetil-ftalazina para a preparação de um medicamento para o tratamento de sìndromes melodisplásicas
BRPI0507985A (pt) derivados de piperazina uréia para o tratamento de endometriose
SE0004827D0 (sv) Therapeutic compounds
BR0316010A (pt) Combinação
CY1106385T1 (el) Χρηση παραγωγων της εποθειλονης για τη θepαπεια του υπepπαραθυρεοειδισμου
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
BR0306632A (pt) Hipoestóxidos, seus derivados e agonistas para uso no tratamento e profilaxia de hiperlipidemia
MX2007002532A (es) Metodos para el tratamiento de enfermedades proliferativas de la piel utilizando derivados de carbazol.
BR0214644A (pt) Uso de derivados de ácido 4-oxobutanóico no tratamento de inflamação
EA200701086A1 (ru) Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.